Kane Logo Cropped TransBG.png
Kane Biotech Announces Positive Efficacy Results in STEM Pet Oral Care Clinical Trial
March 10, 2021 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, March 10, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today that preliminary analysis of data from efficacy trials...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Launch of New Human Health OTC DermaKB™ Product Line
December 10, 2020 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Third Quarter 2020 Financial Results
November 26, 2020 17:31 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Appoints New Advisor
September 23, 2020 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Company,” “Kane Biotech”) today announced that it has entered into an agreement with Harbor Access...
ADTX.jpg
Aditx Therapeutics Announces Pricing of $9.6 Million Follow-On Public Offering
September 02, 2020 08:30 ET | Aditx Therapeutics, Inc.
LOMA LINDA, CA, Sept. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies...
Shineco.png
Shineco, Inc. Announces the Completion of its First Board Meeting for Fiscal Year 2019
December 06, 2019 09:00 ET | Shineco, Inc.
BEIJING, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp...
arbor-logo-tree-color.png
Arbor Biotechnologies Announces Issuance of U.S. Patent for CRISPR-Cas13d
September 25, 2019 09:16 ET | Arbor Biotechnologies Inc
CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company, today announced that the United States Patent and Trademark Office (USPTO) has...
Shineco.png
Shineco, Inc. Enters into Strategic Cooperation Frame Agreement with Shenzhen Datong Industrial Co., Ltd
April 22, 2019 08:30 ET | Shineco, Inc.
BEIJING, April 22, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce,...
NEOVACS STRENGTHENS
NEOVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS
March 27, 2019 07:45 ET | NEOVACS
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS Paris and...
Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform
March 15, 2018 12:00 ET | Arbor Biotechnologies Inc
 Findings Published in the Journal Molecular Cell   $15 Million Series A Financing to Scale Biodiscovery CAMBRIDGE, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early stage...